Abstract
Nakamura et al. examined the evidence, using a discovery and a validation database, that amyloid-β precursor protein (APP)669–711/amyloid-β (Aβ)1–42 and Aβ1–40/Aβ1–42 ratios, and composites based on traditional statistics; they concluded that these may be useful as biomarkers of Alzheimer’s Disease (AD). We reexamined the same datasets, each of which included cognitively normal individuals (CN), individuals with mild cognitive impairment (MCI) and individuals with AD. We used fractal self-similar analyses and reexamined their data from (1) the Japanese National Center for Geriatrics and Gerontology (NCGG) (discovery database) and (2) the Australian Imaging, Biomarker and Lifestyle Study of Ageing (AIBL) cohort (validation database). Results: Using our methods, the three groups of individuals were found to be self-similar, i.e., they could not be differentiated quantitatively, in contrast to the findings of Nakamura et al. Conclusion: Appropriate biomarkers need further study. Our results suggest that APP669–711/Aβ1–42 and Aβ1–40/Aβ1–42 ratios and their composites may not be valid biomarkers of AD, when reexamined using fractal methods for comparing biomarkers across populations.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Harte J, Kinzig A, Green J (1999) Self-similarity in the distribution and abundance of species. Science 284(5412):334–336
Honig LS, Vellas B, Woodward M et al (2018) Trial of Solanezumab for mild dementia due to Alzheimer’s disease. N Engl J Med 378(4):321–330
Lamb SE, Sheehan B, Atherton N, Nichols V, Collins H, Mistry D, Dosanjh S, Slowther AM, Khan I, Petrou S, Lall R et al (2018) Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial. BMJ 361:k1675
Liu TC, Liu G, Hu SJ et al (2017) Quantitative biology of exercise-induced signal transduction pathways. Adv Exp Med Biol 977:419–424
Liu TCY, Tang XM, Duan R et al (2018) The mitochondrial Na+/Ca2+ exchanger is necessary but not sufficient for Ca2+ homeostasis and viability. Adv Exp Med Biol 1072:281–285
Mohanty JG, Eckley DM, Williamson JD et al (2008) Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer’s disease? Adv Exp Med Biol 614:29–35
Nakamura A, Kaneko N, Villemagne VL et al (2018) High performance plasma amyloid-Beta biomarkers for Alzheimer’s disease. Nature 554(7691):249–254
West G (2017) Scale: the universal Laws of growth, innovation, sustainability, and the pace of life in organisms, cities, economies, and companies. Penguin Press, New York
Wu C, Yang L, Tucker D et al (2018) Beneficial effects of exercise pretreatment in a sporadic Alzheimer’s rat model. Med Sci Sports Exerc 50(5):945–956
Acknowledgments
This work was supported by The National Key Research and Development Program of China (2017YFB0403800).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Liu, T.CY., Zheng, T., Duan, R., Zhu, L., Zhang, QG. (2020). On the Biomarkers of Alzheimer’s Disease. In: Ryu, PD., LaManna, J., Harrison, D., Lee, SS. (eds) Oxygen Transport to Tissue XLI. Advances in Experimental Medicine and Biology, vol 1232. Springer, Cham. https://doi.org/10.1007/978-3-030-34461-0_52
Download citation
DOI: https://doi.org/10.1007/978-3-030-34461-0_52
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34459-7
Online ISBN: 978-3-030-34461-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)